The biopharmaceutical firm MannKind Corporation shares jumped more than 16 percent on Wednesday after a web site speculated the company is a ripe takeover target. Gilead Sciences Inc disclosed that its... More
-
Latest News
-
Tech News
-
The biopharmaceutical firm MannKind Corporation shares jumped more than 16 percent on Wednesday after a web site speculated the company is a ripe takeover target. Gilead Sciences Inc disclosed that its... More
Solar shares of the major solar companies are plummeting on Wednesday, as compared to Tuesday when mostly solar stocks soared as the solar product shipments begin ticking up and the Chinese-based renewable... More
Sony Corporation (ADR) (NYSE:SNE) shared about its PlayStation 4 gaming console and said that it would be supercharged PC much like the Xbox. That is a vital departure from the earlier PlayStation design... More
Advanced Micro Devices (NYSE:AMD) is reported to become the main chip supplier for the Xbox One recently launched by Microsoft Corporation on Tuesday. AMD will deliver an integrated GPU and CPU for the... More
Analysts at Piper Jaffray have raised the price target for Zynga Inc (NASDAQ:ZNGA) from 2.75 US dollars to 3.50 US dollars and also disclosed a neutral rating on the shares. Yingli Green Energy Holding... More
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) recently reported at UBS Global Healthcare Conference that its first quarter sales were strong at 6.4 million US dollars. Affymax, Inc. (NASDAQ:AFFY) recently... More
During Monday trade shares of SunPower Corporation (NASDAQ:SPWR) hit a new 52 week high as it is currently trading at 22.50 US dollars and higher than its previous 52 week high of 22.38 US dollars with... More
Its been discussed that Facebook (NASDAQ:FB) could face some possible threat from Yahoo’s appetite for Tumblr. Yahoo intends to turn Tumblr into another social media name that result in increased rivalry... More
Analysts at UBS have raised the price target for Advanced Micro Devices, Inc. (NYSE:AMD) shares from 2.75 to 4.50 US dollars and also maintained its Neutral rating due to balanced risk reward. On the basis... More
Shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) surged as much as 34 percent after the company signed an agreement with the Food and Drug Administration for Bavituximab for its late stage trial. ACADIA... More